Status:
COMPLETED
Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection
Lead Sponsor:
Groupe Hospitalier Diaconesses Croix Saint-Simon
Collaborating Sponsors:
Cosmo Artificial Intelligence-AI Ltd
Conditions:
Colon Cancer
Colon Polyp
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to assess whether the use of artificial intelligence improves polyp detection in a segment of the colon (the right colon). To achieve this objective, patients will be divided ...
Detailed Description
Colorectal cancer (CRC) is the third most common cancer and remains one of the leading causes of mortality among neoplastic diseases in the world. Screening colonoscopy with detection and resection of...
Eligibility Criteria
Inclusion
- Age\>18 years
- Signed informed consent
- Affiliated to or beneficiary of a social security scheme
Exclusion
- Patients with history of inflammatory bowel diseases
- Patients with history of familial polyposis syndrome
- Patients with history of right colonic resection.
- Pregnant or breastfeeding women
- Patient benefiting from a legal protection measure : tutorship, curatorship, patient deprived of freedom
- Adults who are unable to give their consent
- People under psychiatric care who are not able to understand the aim if this research
Key Trial Info
Start Date :
January 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06216405
Start Date
January 20 2022
End Date
January 3 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Diaconesses Croix Saint-Simon
Paris, Île-de-France Region, France, 75020